Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Study to Evaluate Safety and Pharmacokinetics/Pharmacodynamics of Sustained Release(SR) Exenatide

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Peptron, Inc.
ClinicalTrials.gov Identifier:
NCT00964262
First received: August 21, 2009
Last updated: July 18, 2013
Last verified: May 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2010
  Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)
No publications provided by Peptron, Inc.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):